O Hospital Beatriz Ângelo é um hospital multivalente integrado no Serviço Nacional de Saúde localizado em Loures, Portugal. Foi inaugurado a 19 de janeiro de 2012, embora só em 27 de fevereiro desse ano é que foi aberto o serviço de Urgência Geral, concluindo assim a instalação de todos os serviços.

During the past decade, Hospital Beatriz Angelo conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 9 clinical trials were completed, i.e. on average, 17.3% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 8 clinical trials were completed. i.e. 25.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Beatriz Angelo" #1 sponsor was "Hospital Beatriz Ângelo" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Celgene" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Beatriz Angelo" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Alliance Foundation Trials, LLC." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene, Ltd." with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Beatriz Angelo" are "Crohn Disease" (6 trials), "Crohn's Disease" (3 trials), "Depressive Disorder, Major" (3 trials), "Alzheimer's Disease" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hospital Beatriz Angelo" in a lesser frequency.

Most popular intervention types in "Hospital Beatriz Angelo" are "Drug" (43 trials), "Other" (5 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Beatriz Angelo" are 46 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are 32 active trials in "Hospital Beatriz Angelo". 1 are not yet recruiting, 24 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Hospital Beatriz Angelo, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Beatriz Angelo, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".